ClinicalTrials.gg
Status unknownNCT04054700Updated Sep 16, 2021

The Effect of Application of Proximal and Distal Upper Rehabilitation Robot With Stroke Patients

An interventional study of distal upper rehabilitation robot and proximal upper rehabilitation robot in Stroke, sponsored by National Rehabilitation Center, Seoul, Korea. Status unknown at 1 site in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2021-09-16.

Sponsored by National Rehabilitation Center, Seoul, Korea · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 20 studies in Stroke by National Rehabilitation Center, Seoul, Korea — none open to participants now, none under way, none of them phase 3. Stroke · National Rehabilitation Center, Seoul, Korea.

Planned enrollment
2nd of 19
68 · median 30
Started
2019
with 1 other
No phase
17 of 20
none open now
Registered
17th of 20
by date

Among the 20 studies in Stroke by National Rehabilitation Center, Seoul, Korea, this one is the 2nd largest by planned enrollment of the 19 interventional ones that give a count, is one of 2 that started in 2019, is one of 17 with no phase, and was the 17th registered.

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

Browse Stroke studies →

Open to participants now

None of the 20 studies in Stroke by National Rehabilitation Center, Seoul, Korea is open now. The open studies under Stroke, anywhere →

Where they have run

Who these studies take

Of the 1,415 Stroke studies recruiting now, 697 (49%) set no upper age limit and 280 (20%) stop at 75 or younger; 77 take children under 18; 196 take healthy volunteers.

This study: 19 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 20 studies in Stroke by National Rehabilitation Center, Seoul, Korea as a file.
02

Study summary

Comparison of the effect of upper limb rehabilitation on the application of proximal upper rehabilitation robot and distal upper rehabilitation robot with stroke patients

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • upper limb rehabilitation
  • stroke
  • proximal upper rehabilitation robot
  • distal upper rehabilitation robot
04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Hemiplegic patients secondary to first cerebrovascular accidents
  • Onset ≥ 3 months
  • 29 ≤ Fugl-Meyer Assessment score
  • Cognitively intact enough to understand and follow the instructions from the investigator

Exclusion criteria

Exclusion Criteria:

  • History of surgery of affected upper limb
  • Fracture of affected upper limb
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
68 participants (estimated)

Study arms

  • Experimental
    distal upper rehabilitation robot

    experimental group that applied the distal upper rehabilitation robot

    Device: distal upper rehabilitation robot

  • Other
    proximal upper rehabilitation robot

    control group that applied the proximal upper rehabilitation robot

    Device: proximal upper rehabilitation robot

Interventions

  • Devicedistal upper rehabilitation robot

    Intervention with distal upper rehabilitation robot

  • Deviceproximal upper rehabilitation robot

    Intervention with proximal upper rehabilitation robot

06

What researchers measure

Primary outcomes

  1. Wolf motor function test

    an activity indicator, has 15 items for testing functional ability

    Time frame: change from baseline at 4 weeks

  2. Fugl-Meyer Assessment

    indicator of the level of impairment of upper extremity, with higher scores indicating lower impairment

    Time frame: change from baseline at 4 weeks

Secondary outcomes

  1. Fugl-Meyer Assessment

    indicator of the level of impairment of upper extremity, with higher scores indicating lower impairment

    Time frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  2. Motor activity log

    Assesses the use of the paretic arm and hand during activities of daily living in hemiparetic stroke patients.

    Time frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  3. Action reach arm test

    to assess upper extremity performance (coordination, dexterity and functioning) in stroke recovery

    Time frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  4. Motor status score

    evaluate the impairment level

    Time frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  5. Box and block test

    measures unilateral gross manual dexterity

    Time frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  6. Wolf motor function test

    an activity indicator, has 15 items for testing functional ability

    Time frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  7. Mean velocity of upper extremity during reaching task

    Mean velocity of the magnetic sensor trajectory (Kinematics of upper extremity during) reaching task

    Time frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  8. Curvature of upper extremity during reaching task

    Curvature of the magnetic sensor trajectory (Kinematics of upper extremity during) reaching task

    Time frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  9. Jerk of upper extremity during reaching task

    Jerk of the magnetic sensor trajectory (Kinematics of upper extremity during) reaching task

    Time frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  10. Motor evoked potential over motor cortex of the affected side

    Motor evoked potential elicited by noninvasive stimulation (rTMS) of the motor cortex

    Time frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  11. Stroke impact scale 3.0

    Total score and individual domain score of stroke impact scale

    Time frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

07

Study locations

1 of 1 sites recruiting
  • National Rehabilitation Center
    Seoul, 142884, Korea, Republic of
    Recruiting
    • Joon-Ho Shin, MS · Contact
    • Joon-Ho Shin, MS · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2019 (actual). Primary completion is estimated for Dec 2022, 38 months after the start.

Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 38 months is above that.

Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 12, 2019
First posted
Aug 13, 2019
StartActual
Oct 1, 2019
Primary completionEst.
Dec 31, 2022
CompletionEst.
Dec 31, 2022
Last update
Sep 16, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04054700
Lead sponsor
National Rehabilitation Center, Seoul, Korea
Responsible party
Joon-Ho Shin (Team manager, National Rehabilitation Center, Seoul, Korea) — Principal investigator
First posted
Aug 13, 2019
Start date
Oct 1, 2019
Primary completion
Dec 31, 2022 (estimated)
Completion
Dec 31, 2022 (estimated)
Last update
Sep 16, 2021

Study contacts

Joon-Ho Shin, MS
Contact
asfreelyas@gmail.com
82-2-901-1884
Joon-Ho Shin, MS
principal investigator · National Rehabilitation Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion